Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

Roche Diagnostics says it has developed blood tests to help rule out a diagnosis of Alzheimer’s disease in the broad population, thus narrowing who might be suffering from the disease. Nearly 7 ...

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) has launched COVID-19 PCR test which detects a fast spreading Omicron sub-variant XBB.1.5. The Swiss pharma giant said its subsidiary TIB Molbiol developed the test ...

Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks.1 ...

Basel, 24 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its COVID-19 At-Home ...

While last year saw a wave of COVID-19 test sales crest as routine diagnostics began to rebound, companies are now cashing in on both sides of the coin. Roche’s diagnostics division saw strong revenue ...

The rollout comes amid long lines at testing sites and President Joe Biden's promise to increase the number of tests available. Healthcare giant Roche will roll out "tens of millions" of at-home Covid ...

Roche Diagnostics in Indianapolis has launched Pilot, the new brand for its COVID-19 at-home test. The company announced this week that the test, which received an Emergency Use Authorization from the ...